Related Experiment Video
Updated: Dec 30, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
AGO2 Mediates MYC mRNA Stability in Hepatocellular Carcinoma
Kai Zhang1,2, Yotsawat Pomyen3,4, Anna E Barry1,2
1Department of Surgery, Department of Surgical Research, Thomas Jefferson University, Philadelphia, Pennsylvania.
Abstract:
Deregulated RNA-binding proteins (RBP), such as Argonaute 2 (AGO2), mediate tumor-promoting transcriptomic changes during carcinogenesis, including hepatocellular carcinoma (HCC). While AGO2 is well characterized as a member of the RNA-induced silencing complex (RISC), which represses gene expression through miRNAs, its role as a bona fide RBP remains unclear. In this study, we investigated AGO2's role as an RBP that regulates the MYC transcript to promote HCC. Using mRNA and miRNA arrays from patients with HCC, we demonstrate that HCCs with elevated AGO2 levels are more likely to have the mRNA transcriptome deregulated and are associated with poor survival. Moreover, AGO2 overexpression stabilizes the MYC transcript independent of miRNAs. These observations provide a novel mechanism of gene regulation by AGO2 and provide further insights into the potential functions of AGO2 as an RBP in addition to RISC. IMPLICATIONS: Authors demonstrate that the RBP Argonaute 2 stabilizes the MYC transcript to promote HCC.
Insights
Argonaute 2 (AGO2), a RNA-binding protein, promotes hepatocellular carcinoma (HCC) by stabilizing the MYC transcript. This discovery reveals a new mechanism for gene regulation in cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Deregulated RNA-binding proteins (RBPs) contribute to cancer development, including hepatocellular carcinoma (HCC).
- Argonaute 2 (AGO2) is known for its role in the RNA-induced silencing complex (RISC) but its function as a general RBP is less understood.
- The oncogenic role of MYC in HCC is well-established.
Purpose of the Study:
- To investigate the role of Argonaute 2 (AGO2) as a RNA-binding protein (RBP) in hepatocellular carcinoma (HCC).
- To determine if AGO2 regulates the MYC transcript in HCC.
- To elucidate novel mechanisms of gene regulation by AGO2 in cancer.
Main Methods:
- Analysis of mRNA and miRNA expression arrays from HCC patients.
- Correlation of AGO2 expression levels with transcriptomic deregulation and patient survival.
- Experimental validation of AGO2's effect on MYC transcript stability, independent of microRNA (miRNA) activity.
Main Results:
- Elevated AGO2 levels in HCC correlate with a deregulated mRNA transcriptome and poorer patient survival.
- AGO2 overexpression was found to stabilize the MYC transcript in HCC.
- This stabilization effect of AGO2 on MYC occurs independently of miRNA-mediated repression.
Conclusions:
- Argonaute 2 (AGO2) functions as a potent RNA-binding protein (RBP) that promotes hepatocellular carcinoma (HCC) by stabilizing the MYC oncogene transcript.
- This study uncovers a novel mechanism of gene regulation by AGO2 beyond its canonical role in the RNA-induced silencing complex (RISC).
- These findings highlight AGO2 as a potential therapeutic target for HCC treatment.
More Related Videos
04:29Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
Published on: November 1, 2024
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators